AdvisorShares Psychedelics ETF (PSIL)
| Assets | $33.65M |
| Expense Ratio | 1.00% |
| PE Ratio | n/a |
| Shares Out | 1.70M |
| Dividend (ttm) | $1.72 |
| Dividend Yield | 8.49% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 6,574 |
| Open | 20.00 |
| Previous Close | 19.87 |
| Day's Range | 19.55 - 20.21 |
| 52-Week Low | 12.39 |
| 52-Week High | 22.49 |
| Beta | 1.00 |
| Holdings | 32 |
| Inception Date | Sep 15, 2021 |
About PSIL
Fund Home PageThe AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.
Top 10 Holdings
67.78% of assets| Name | Symbol | Weight |
|---|---|---|
| COMPASS Pathways plc | CMPS | 10.92% |
| AtaiBeckley Inc. | ATAI | 9.88% |
| Relmada Therapeutics, Inc. | RLMD | 8.57% |
| Definium Therapeutics, Inc. | DFTX | 8.04% |
| GH Research PLC | GHRS | 6.30% |
| NRx Pharmaceuticals, Inc. | NRXP | 5.87% |
| Neurocrine Biosciences, Inc. | NBIX | 5.21% |
| Alkermes plc | ALKS | 4.49% |
| Bright Minds Biosciences Inc. | DRUG | 4.43% |
| AbbVie Inc. | ABBV | 4.09% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.6839 | Dec 29, 2025 |
| Sep 22, 2025 | $0.0201 | Sep 29, 2025 |
| Jun 23, 2025 | $0.01191 | Jun 27, 2025 |
| Mar 21, 2025 | $0.16343 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0548 | Dec 30, 2024 |
| Sep 23, 2024 | $0.1087 | Sep 30, 2024 |
Performance
PSIL had a total return of 66.94% in the past year, including dividends. Since the fund's inception, the average annual return has been -26.91%.
News
AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies
Portfolio manager of the AdvisorShares Psychedelics ETF (PSIL) calls executive action a pivotal moment for psychedelic medicine BETHESDA, Md., April 20, 2026 /PRNewswire/ -- AdvisorShares, a leading s...
High-Momentum ETFs Leading the Market This Year
The S&P 500 experienced an impressive return of close to 25% in 2024, significantly outpacing its average annual growth rate over the last several decades, which is much closer to 10%. After another s...